Hoba, Therapeutics Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain 07.08.2025 - 18:05:22 Hoba Therapeutics Denmark View original content:https://www.prnewswire.co.uk/news-releases/hoba-therapeutics-raises-eur-23-million-in-a-series-a-to-advance-new-drug-candidate-against-chronic-neuropathic-pain-302010139.html